C Paraskeva

2.4k total citations
21 papers, 1.9k citations indexed

About

C Paraskeva is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, C Paraskeva has authored 21 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Molecular Biology and 6 papers in Cancer Research. Recurrent topics in C Paraskeva's work include Colorectal Cancer Treatments and Studies (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Genetic factors in colorectal cancer (4 papers). C Paraskeva is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Inflammatory mediators and NSAID effects (5 papers) and Genetic factors in colorectal cancer (4 papers). C Paraskeva collaborates with scholars based in United Kingdom, United States and Australia. C Paraskeva's co-authors include Angela Hague, Andrew Hague, Daniel Hicks, Douglas J.E. Elder, L. I. Huschtscha, David A. Hart, Anthony M. Manning, Ann C. Williams, M Moorghen and Matthew Chapman and has published in prestigious journals such as Oncogene, British Journal of Cancer and Cell Death and Differentiation.

In The Last Decade

C Paraskeva

21 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C Paraskeva United Kingdom 17 1.0k 606 451 378 346 21 1.9k
Jason R. Mann United States 13 491 0.5× 350 0.6× 706 1.6× 332 0.9× 309 0.9× 14 1.4k
Hiroyuki Achiwa Japan 15 605 0.6× 659 1.1× 753 1.7× 329 0.9× 449 1.3× 28 1.7k
Adil Akhtar United States 7 552 0.5× 476 0.8× 234 0.5× 186 0.5× 127 0.4× 20 1.2k
Joanne R. Brown United Kingdom 11 459 0.4× 339 0.6× 463 1.0× 234 0.6× 215 0.6× 13 1.3k
R J Coffey United States 14 1.0k 1.0× 866 1.4× 1.6k 3.5× 609 1.6× 931 2.7× 15 3.1k
Xiao-Chun Xu United States 24 982 0.9× 309 0.5× 212 0.5× 432 1.1× 413 1.2× 32 1.7k
Tong Wu United States 31 1.6k 1.5× 351 0.6× 266 0.6× 1.1k 3.0× 199 0.6× 80 2.9k
Adel Kardosh United States 19 424 0.4× 419 0.7× 284 0.6× 135 0.4× 109 0.3× 75 1.4k
Arianna L. Kim United States 26 1.4k 1.3× 515 0.8× 184 0.4× 247 0.7× 293 0.8× 39 2.3k
Petra Wilgenbus Germany 17 1.5k 1.4× 653 1.1× 149 0.3× 345 0.9× 219 0.6× 22 2.5k

Countries citing papers authored by C Paraskeva

Since Specialization
Citations

This map shows the geographic impact of C Paraskeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C Paraskeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C Paraskeva more than expected).

Fields of papers citing papers by C Paraskeva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C Paraskeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C Paraskeva. The network helps show where C Paraskeva may publish in the future.

Co-authorship network of co-authors of C Paraskeva

This figure shows the co-authorship network connecting the top 25 collaborators of C Paraskeva. A scholar is included among the top collaborators of C Paraskeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C Paraskeva. C Paraskeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Morgan, Gareth, Elek Molnár, Raymond F. Jones, et al.. (2015). Nutrient stress alters the glycosylation status of LGR5 resulting in reduced protein stability and membrane localisation in colorectal tumour cells: implications for targeting cancer stem cells. British Journal of Cancer. 112(4). 714–719. 12 indexed citations
2.
Smartt, Helena J.M., Alexander Greenhough, Paloma Ordóñez‐Morán, et al.. (2012). β-catenin negatively regulates expression of the prostaglandin transporter PGT in the normal intestinal epithelium and colorectal tumour cells: a role in the chemopreventive efficacy of aspirin?. British Journal of Cancer. 107(9). 1514–1517. 7 indexed citations
3.
Dallosso, Anthony R., Bodil Øster, Alexander Greenhough, et al.. (2012). Long-range epigenetic silencing of chromosome 5q31 protocadherins is involved in early and late stages of colorectal tumorigenesis through modulation of oncogenic pathways. Oncogene. 31(40). 4409–4419. 60 indexed citations
5.
Moore, Alice E., Alexander Greenhough, H R Roberts, et al.. (2009). HGF/Met signalling promotes PGE2 biogenesis via regulation of COX-2 and 15-PGDH expression in colorectal cancer cells. Carcinogenesis. 30(10). 1796–1804. 48 indexed citations
6.
7.
Williams, Ann C., et al.. (2006). Insulin-like growth factor binding protein 3 (IGFBP-3) potentiates TRAIL-induced apoptosis of human colorectal carcinoma cells through inhibition of NF-κB. Cell Death and Differentiation. 14(1). 137–145. 58 indexed citations
8.
Hague, Angela, et al.. (2005). Increased sensitivity to TRAIL-induced apoptosis occurs during the adenoma to carcinoma transition of colorectal carcinogenesis. British Journal of Cancer. 92(4). 736–742. 35 indexed citations
9.
Chell, Simon, David Qualtrough, Daniel Hicks, et al.. (2005). Prospects in NSAID-derived chemoprevention of colorectal cancer. Biochemical Society Transactions. 33(4). 667–671. 20 indexed citations
10.
Hague, Angela & C Paraskeva. (2004). Apoptosis and disease: a matter of cell fate. Cell Death and Differentiation. 11(12). 1366–1372. 23 indexed citations
11.
Hague, Angela, et al.. (1997). Cell-cell contact and specific cytokines inhibit apoptosis of colonic epithelial cells: growth factors protect against c-myc-independent apoptosis. British Journal of Cancer. 75(7). 960–968. 44 indexed citations
12.
Elder, Douglas J.E., et al.. (1997). Induction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 (COX-2)-selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression.. PubMed. 3(10). 1679–83. 324 indexed citations
13.
Hague, Angela, et al.. (1996). Differential growth inhibition by the aspirin metabolite salicylate in human colorectal tumor cell lines: enhanced apoptosis in carcinoma and in vitro-transformed adenoma relative to adenoma relative to adenoma cell lines.. PubMed. 56(10). 2273–6. 153 indexed citations
14.
Williams, Ann C., et al.. (1995). Mutant p53 is not fully dominant over endogenous wild type p53 in a colorectal adenoma cell line as demonstrated by induction of MDM2 protein and retention of a p53 dependent G1 arrest after gamma irradiation.. PubMed. 11(1). 141–9. 20 indexed citations
15.
Hague, Angela, M Moorghen, Daniel Hicks, Matthew Chapman, & C Paraskeva. (1994). BCL-2 expression in human colorectal adenomas and carcinomas.. PubMed. 9(11). 3367–70. 148 indexed citations
16.
Paraskeva, C, et al.. (1993). TGF-β expression in the human colon: differential immunostaining along crypt epithelium. British Journal of Cancer. 68(1). 137–139. 100 indexed citations
18.
Williams, Ann C., et al.. (1993). Biological consequences of the genetic changes which occur during human colorectal carcinogenesis.. PubMed. 4(3). 153–9. 14 indexed citations
19.
Corfield, Anthony P., S A Wagner, C Paraskeva, et al.. (1992). Loss of sialic acid O-acetylation in human colorectal cancer cells. Biochemical Society Transactions. 20(2). 94S–94S. 17 indexed citations
20.
Hague, Angela, et al.. (1992). CLONAL EVOLUTION AND TUMOR PROGRESSION IN 2 HUMAN COLORECTAL ADENOMA-DERIVED CELL-LINES INVITRO - THE INVOLVEMENT OF CHROMOSOME-1 ABNORMALITIES. International Journal of Oncology. 1(2). 201–8. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026